Question · asked by 1 review
Methylprednisolone plus azathioprine vs methylprednisolone plus dapsone: Disease control (time when steroid could be discontinued)
- Population
- bullous pemphigoid
- Intervention
- Methylprednisolone plus azathioprine
- Comparison
- methylprednisolone plus dapsone
- Outcome
- Disease control (time when steroid could be discontinued)
What each review found
Current versions only| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
Methylprednisolone plus azathioprine vs methylprednisolone plus dapsone Disease control (time when steroid could be discontinued) · bullous pemphigoid Interventions for bullous pemphigoid (2023) · Cochrane Headline outcomes only | no estimate extracted | 1 study · 54 participants | Very low |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Interventions for bullous pemphigoid 2023 · Cochrane Headline outcomes only | Not reported | Not extracted | Not assessed |
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.